AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3086
Abstract: To investigate the effect of serum aspartate transaminase/alanine transaminase (AST/ALT) on the risk of prostate cancer. read more here.
Keywords: cancer; ast alt; prostate cancer; risk prostate ... See more keywords
Treatment patterns and survival of low and intermediate‐risk prostate cancer in end‐stage kidney disease: A retrospective population cohort study
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5571
Abstract: In accordance with guidelines, observation with or without active surveillance for low‐risk prostate cancer increased in recent years in the general population. We compared treatment patterns and mortality for low‐ and intermediate‐risk prostate cancer and… read more here.
Keywords: treatment patterns; risk prostate; prostate cancer; cancer ... See more keywords
Risk of prostate cancer and death after benign transurethral resection of the prostate—A 20‐year population‐based analysis
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34407
Abstract: The oncological risks after benign histology on a transurethral resection of the prostate (TURP) remain largely unknown. Here, the risk of prostate cancer incidence and mortality following a benign histological assessment of TURP is investigated… read more here.
Keywords: prostate cancer; prostate; risk prostate; resection prostate ... See more keywords
Cost effectiveness of treatment strategies for high risk prostate cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34450
Abstract: Patients with high‐risk prostate cancer (HRPC) have multiple accepted treatment options. Because there is no overall survival benefit of one option over another, appropriate treatment must consider patient life expectancy, quality of life, and cost. read more here.
Keywords: prostate cancer; risk prostate; high risk; treatment ... See more keywords
New standard of care for refractory metastatic colorectal cancer
Sign Up to like & getrecommendations! Published in 2023 at "Cancer"
DOI: 10.1002/cncr.34840
Abstract: 1789 One area of focus is developing a multimodality approach that combines systemic therapy and surgery to cure more men with a new diagnosis of localized high-risk prostate cancer, as there is a suboptimal cure… read more here.
Keywords: prostate cancer; risk prostate; high risk; standard ... See more keywords
Acne in late adolescence and risk of prostate cancer
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Cancer"
DOI: 10.1002/ijc.31192
Abstract: Accumulating evidence suggest that Propionibacterium acnes may play a role in prostate carcinogenesis, but data are so far limited and inconclusive. The aim of this population‐based cohort study was therefore to test whether presence of… read more here.
Keywords: prostate; adolescence; prostate cancer; cancer ... See more keywords
Use of vitamin K antagonists and risk of prostate cancer: Meta–analysis and nationwide case–control study
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Cancer"
DOI: 10.1002/ijc.31886
Abstract: Use of vitamin K antagonists (VKAs) has been suggested to reduce the risk of prostate cancer. We conducted a nested case–control study using Danish demographic and health data registries and summarized existing evidence in a… read more here.
Keywords: study; prostate cancer; case; cancer ... See more keywords
Serum core‐type fucosylated prostate‐specific antigen index for the detection of high‐risk prostate cancer
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Cancer"
DOI: 10.1002/ijc.33517
Abstract: It is known that core‐type fucosylation is higher in prostate cancer cells than in other cancer cell types and is associated with high‐risk prostate cancer. Here, we developed an automated microcapillary electrophoresis‐based immunoassay system for… read more here.
Keywords: prostate; psa; prostate cancer; cancer ... See more keywords
A pilot study of MRI radiomics for high‐risk prostate cancer stratification in 1.5 T MR‐guided radiotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Magnetic Resonance in Medicine"
DOI: 10.1002/mrm.29564
Abstract: To investigate the potential value of MRI radiomics obtained from a 1.5 T MRI‐guided linear accelerator (MR‐LINAC) for D'Amico high‐risk prostate cancer (PC) classification in MR‐guided radiotherapy (MRgRT). read more here.
Keywords: mri radiomics; prostate cancer; risk prostate; high risk ... See more keywords
Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance
Sign Up to like & getrecommendations! Published in 2019 at "World Journal of Urology"
DOI: 10.1007/s00345-019-02848-x
Abstract: Purpose To assess the upstaging/upgrading rates of low-risk prostate cancer (PCa) according to the biopsy scheme used (systematic (SB), targeted biopsies (TB), or both) in the setting of positive pre-biopsy MRI. Patients and methods We… read more here.
Keywords: combination; risk; disease; mri ... See more keywords
External beam radiation therapy with or without low-dose-rate brachytherapy: Analysis of favorable and unfavorable intermediate-risk prostate cancer patients.
Sign Up to like & getrecommendations! Published in 2017 at "Brachytherapy"
DOI: 10.1016/j.brachy.2017.04.001
Abstract: PURPOSE To compare the tumor control and toxicity in men with intermediate-risk prostate cancer treated with either external beam radiation therapy (EBRT) or EBRT plus low-dose-rate brachytherapy (combo-RT). METHODS AND MATERIALS Between 1995 and 2012,… read more here.
Keywords: risk; prostate cancer; intermediate risk; toxicity ... See more keywords